Similar Articles
511 Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment
512 Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis
513 Clinical values of Barcelona Clinic Liver Cancer subgroup and up-to-7 criteria in intermediate stage hepatocellular carcinoma with transcatheter arterial chemoembolization
514 miR-3682-3p directly targets FOXO3 and stimulates tumor stemness in hepatocellular carcinoma via a positive feedback loop involving FOXO3/PI3K/AKT/c-Myc
515 Application of intravoxel incoherent motion diffusion-weighted imaging in hepatocellular carcinoma
516 Regulatory T cells and their associated factors in hepatocellular carcinoma development and therapy
517 Risk factors and diagnostic biomarkers for nonalcoholic fatty liver disease-associated hepatocellular carcinoma: Current evidence and future perspectives
518 RING finger and WD repeat domain 3 regulates proliferation and metastasis through the Wnt/β-catenin signalling pathways in hepatocellular carcinoma
519 Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis
520 Enhanced recovery after surgery in liver transplantation: Challenges and feasibility
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA